PLoS ONE, 8:10, e78636
Ethacraplatin a dual-threat platinum (IV) prodrug is a cisplatin molecule coordinated to two ethacrynic acid ligands which is able to inhibit irreversibly GSTP1-1 enzymatic activity being reduced and cleaved as a consequence of binding (Fig
PT-141 Liquid Spray 30mg Intranasal research format of Bremelanotide, the melanocortin receptor agonist
Government healthcare policies and regulations regarding drug pricing and reimbursement play a critical role in determining the affordability and market penetration of GLP-1 receptor agonists
The labeled ladder is 2.5, 5, 7.5, 10, 12.5, and 15 mg once weekly, with each escalation step held for at least four weeks
Studied in models involving amylin receptor signaling, appetite-related pathways, and metabolic response